High Court Agrees To Hear Dispute Over Abortion Drug Regulations

(December 13, 2023, 11:35 AM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court will determine whether the Fifth Circuit U.S. Court of Appeals erred in upholding a district court’s stay of the Food and Drug Administration’s 2016 amendments to mifepristone’s approval and the agency’s 2021 decision not to enforce its regulations during the COVID-19 pandemic, the court announced Dec. 13, granting a petition for a writ of certiorari....

Attached Documents

Related Sections